Sales decline 21.94% to Rs 24.55 crore
Abevmy, co-developed by Biocon Biologics and Viatris, is a biosimilar to Roches Avastin (Bevacizumab) and has been approved by Health Canada across four oncology indications.
Sales rise 56.20% to Rs 836.91 crore
Sales rise 84.62% to Rs 0.24 crore
Sales decline 3.43% to Rs 18.87 crore
Sales rise 9.56% to Rs 56.26 crore
Sales rise 269.22% to Rs 80.38 crore
SGX Nifty: Trading of Nifty 50 index futures on the Singapore stock exchange indicates that the Nifty could surge 236 points at the opening bell. Global markets: Overseas, Asian stocks are trading higher on Friday after China cut a key lending benchmark to support a slowing economy. China cut its five-year loan prime rate (LPR) by 15 basis points on Friday morning, a sharper cut […]
Sales decline 2.54% to Rs 2078.80 crore
Sales rise 101.14% to Rs 438.93 crore

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.